Caregiver-Based Fall Prevention Education in Patients Undergoing Awake Deep Brain Stimulation (CARE-DBS-FALL)
The Effect of Caregiver-Based Fall Prevention Education on Fall Prevention Behaviors and Fall Rates in Patients Undergoing Awake Deep Brain Stimulation: A Randomized Controlled Trial
Awake deep brain stimulation (DBS) is an effective surgical treatment for Parkinson's disease and other movement disorders, but patients remain at high risk of falls after surgery because of gait disturbance, postural instability, cognitive decline and transient postoperative delirium. Primary caregivers are the people in closest contact with these patients before surgery and after discharge, yet no caregiver-based fall prevention approach specific to this group has been tested. This single-center, parallel-group randomized controlled trial aims to evaluate the effect of an AI-supported structured fall prevention education given to primary caregivers before surgery on caregivers' fall prevention behaviors and on patients' postoperative falls and near-falls. Sixty-four patient-primary caregiver dyads will be randomized 1:1 to education plus usual care or usual care alone. Caregiver behaviors will be observed from postoperative day 0 to day 7 (or until discharge) using a structured observation form.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
This is a single-center, two-arm, parallel-group randomized controlled trial with a 1:1 allocation ratio, conducted at the Neurosurgery Clinic of Basaksehir Cam and Sakura City Hospital, Istanbul, Turkiye. The unit of randomization is the patient-primary caregiver dyad; each patient and his/her primary caregiver are assigned to the same group, and only one primary caregiver is enrolled per patient.
Sample size was calculated with G*Power 3.1.9.7 based on a similar randomized controlled trial of caregiver fall prevention education (Wang, Zou & Wang, 2022). Because the reported effect size was large (Cohen's d = 1.14), a more conservative d = 0.80 was used with two-sided alpha = 0.05, 80% power and 1:1 allocation, giving 26 dyads per group (52 in total). Allowing for 15% attrition (dropout, change of primary caregiver, missing observations), 32 dyads per group (64 dyads; 64 patients and 64 caregivers, 128 participants) will be enrolled.
Randomization: Dyads will be allocated by computer-generated block randomization (block size 4) by an independent researcher not involved in recruitment, education or data collection. Allocation concealment will be ensured with sequentially numbered, opaque, sealed envelopes prepared by the same independent researcher; the envelope is opened after written informed consent is obtained and the Patient and Primary Caregiver Descriptive Information Form is completed.
Intervention: In addition to routine clinical care, primary caregivers in the experimental group will receive AI-supported structured fall prevention education in the preoperative period. The content, prepared according to current fall prevention literature, covers safe support during first mobilization, bed-chair transfer, walking and toileting, control of environmental risks, and safe use of assistive walking devices. Education will be delivered face to face by the same researcher, with the same content and materials, in a room separate from patient rooms to minimize contamination between groups. The control group will receive routine clinical care only; for ethical reasons, the education content will be offered to control-group caregivers after data collection is completed.
Data collection: The Patient and Primary Caregiver Descriptive Information Form (26 items) will be completed by face-to-face interview before surgery. Caregivers' fall prevention behaviors will be assessed with the Caregiver Fall Prevention Behavior Observation Form (18 behaviors in 4 sections: first mobilization, bed-chair transfer, corridor walking, assistance with toileting and return; each scored 0-2; content validity assessed by 10 experts). First mobilization is observed on postoperative day 0, and the other three sections daily on postoperative days 1-7 (or until discharge if earlier). Falls and near-falls are recorded for each section and day. Observations are performed simultaneously and independently by two trained observers; if a fall risk arises during observation, observers intervene to ensure patient safety and the event is recorded as a near-fall.
Analysis: Data will be analyzed with IBM SPSS by an independent statistician blinded to group allocation, following the intention-to-treat principle, with 95% confidence intervals and p < 0.05. Because the number of applicable behaviors differs between days, the daily mean behavior score (daily total divided by the number of observed behaviors; range 0-2) will be used, and its change over time will be analyzed with linear mixed-effects models (group, time and group-by-time interaction). Fall and near-fall counts will be analyzed with Poisson or, if needed, negative binomial regression. Inter-observer agreement will be assessed with weighted Cohen's kappa and intraclass correlation coefficient. Reporting will follow the CONSORT statement.
Tipo de estudo
Tipo de estudo
Inscrição (Estimado)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
Contato de estudo
- Nome: Kübra Can
- Número de telefone: +90 543 871 17 95
- E-mail: kubracan@halic.edu.tr
Locais de estudo
-
-
Basaksehir
-
Istanbul, Basaksehir, Turquia (Türkiye), 34480
- Basaksehir Cam and Sakura City Hospital, Neurosurgery Clinic
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
Patients:
- Aged 18 years or older
- Scheduled for awake deep brain stimulation surgery
- Able to communicate in Turkish
- Having a primary caregiver who will accompany the patient during the hospital stay
- Agreeing to participate in the study
Primary caregivers:
- Aged 18 years or older
- Being the patient's primary caregiver
- Taking part in the patient's care and the planned observations during the postoperative hospital stay
- Able to read and write in Turkish
- Agreeing to participate in the study
Exclusion Criteria:
Patients:
- Need for prolonged intensive care after surgery
- Development of a serious clinical complication preventing the planned mobilization and observations
- Transfer to another institution before completion of the study
- Request of the patient or legal representative to withdraw from the study
Primary caregivers:
- Not completing the structured education program (experimental group)
- Being unable to continue accompanying the patient in hospital
- Change of the primary caregiver during the study
- Request to withdraw from the study
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Experimental: Caregiver Fall Prevention Education
Primary caregivers receive AI-supported structured fall prevention education, delivered face to face in the preoperative period, in addition to the clinic's routine care and information. |
Face-to-face structured education delivered by the same researcher to the primary caregiver before awake DBS surgery, using standardized AI-supported materials prepared according to current fall prevention literature. Content: safe support of the patient during first mobilization, bed-chair transfer, walking and toileting; control of environmental fall risks; and safe use of assistive walking devices. Education is given in a room separate from patient rooms. |
|
Sem intervenção: Usual Care
Patient-caregiver dyads receive only the clinic's routine care and information. For ethical reasons, the education content will be offered to caregivers after data collection is completed. |
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Mean Caregiver Fall Prevention Behavior Score
Prazo: Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)
|
Measured with the Caregiver Fall Prevention Behavior Observation Form developed by the researchers (18 behaviors in 4 sections: first mobilization [5], bed-chair transfer [4], corridor walking [5], assistance with toileting and return [4]). Each behavior is scored 0 = not performed/performed incorrectly, 1 = partially correct, 2 = fully correct; behaviors not observed or not required on a given day are coded as not observed and excluded. Because the number of applicable behaviors differs between days, the daily mean behavior score (daily total score divided by the number of observed behaviors; range 0-2) is used to assess change over time; higher scores indicate more accurate and complete fall prevention behaviors. Observations are made independently by two trained observers. |
Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Number of Patient Falls During Postoperative Hospitalization
Prazo: Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)
|
Number and rate of patient falls observed during the postoperative hospital stay, recorded as yes/no for each observed activity and day on the Caregiver Fall Prevention Behavior Observation Form. |
Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)
|
|
Number of Near-Fall Events During Postoperative Hospitalization
Prazo: Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)
|
Number and rate of near-fall events (situations in which a fall risk arose and the observers intervened to ensure patient safety) during the postoperative hospital stay. |
Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Colaboradores
Colaboradores
Investigadores
Investigadores
- Investigador principal: Emine Güngör Turan, MSc, Specialist Nurse, Başakşehir Çam & Sakura City Hospital
- Cadeira de estudo: Fatma Eti Aslan, Prof. Dr., Bahçeşehir University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Início do estudo
Conclusão Primária (Estimado)
Conclusão Primária
Conclusão do estudo (Estimado)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
Outros números de identificação do estudo
- HALIC-2026-DBS-FALL
- KAEK-326 (Outro identificador: Basaksehir Cam and Sakura City Hospital Clinical Research Ethics Committee)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Individual participant data will not be shared in order to protect participant confidentiality.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .